Ipamorelin: Sleep, Recovery and Reported Doses
Sleep, recovery and body composition
People research ipamorelin hoping to sleep better, recover between workouts and change their physique. It prompts growth-hormone release rather than supplying HGH itself.
Human research demonstrates a hormone response. Predictable sleep, muscle and recovery benefits remain unestablished, especially for the blends commonly discussed.
A signal, not HGH itself
Ipamorelin The incoming signal
Your pituitary Releases growth hormone
Sleep Recovery Muscle
Reported amount, frequency and course
The CXPeptides supplier sheet describes this muscle-building/fat-reduction example. It is a reported-use example, not proof of either benefit or a validated safe cycle.
200–300 mcg
Per administration
Under the skin in this supplier example.
Once daily
Reported frequency
This is also the daily total in that example.
8–12 weeks
Reported course
A supplier description, not a studied recovery deadline.
The amounts, route and course were rechecked October 12, 2026.
| Practical question | Useful distinction |
|---|---|
| Solo or a CJC blend? | A response while using two drugs cannot identify which caused it |
| Morning or bedtime? | The IV hormone-response study did not establish the best home-use time |
| A larger scale weight? | Fluid, fat and muscle can all change body weight |
Keep per-dose amount separate from daily total: taking an amount twice daily doubles that day’s total. The source example above is once daily, not permission to repeat it whenever sleep or recovery feels poor.
What ipamorelin is
Ipamorelin is a five-amino-acid growth hormone secretagogue: “secretagogue” simply means something that stimulates secretion. It acts through the ghrelin receptor, a different target from the GHRH receptor used by sermorelin. It is also different from injecting GH itself.
Mechanism of action
The drug in blood, the GH pulse it triggers and a change in sleep or strength are different measurements. A larger hormone response does not by itself establish a better result.
The often-cited 1998 “selective secretagogue” paper studied cells and animals. Its comparatively selective GH response does not prove that long-term use in people has no cortisol, prolactin or metabolic effects. Raun et al.
Pharmacokinetics
In a healthy-male volunteer study, 15-minute intravenous infusions produced a terminal ipamorelin half-life of about two hours. GH peaked around 0.67 hours after dosing began. Those are two different measurements: peptide elimination and hormone response. The study does not provide a validated subcutaneous absorption rate or establish the often-repeated 60% subcutaneous bioavailability figure. Gobburu et al.
A curve using the two-hour figure can illustrate decline under that assumption. Its height and peak after a subcutaneous injection require additional assumptions. Check the model information on the compound page before interpreting it as a predicted blood measurement.
Research dosing context
The supplier example above and the monitored IV studies answer different questions. The studies do not validate the supplier’s course or prove a preferred bedtime schedule. A short peptide half-life does not establish how often someone needs a GH response.
Evidence and honest assessment
A phase 2 study examined ipamorelin for bowel recovery after surgery, a very different question from body composition or athletic recovery. That research does not establish benefits for those popular uses. FDA’s assessment also identifies inadequate evidence for subcutaneous effectiveness and safety. FDA assessment
Side effect profile
The meaningful questions are broader than whether a product causes hunger: what happens to glucose regulation, fluid retention and IGF-1 with repeated use, and what is actually in the injectable? FDA identifies peptide impurities and immune-response concerns and insufficient safety information for some injectable routes. A short-term GH response cannot answer those questions.
Frequently asked questions
Is ipamorelin the same as HGH?
No. Ipamorelin stimulates GH release; recombinant GH supplies the hormone directly. Their doses and concentration curves are not interchangeable.
Why do people stack ipamorelin with CJC-1295?
The rationale is to stimulate two receptor pathways. That does not demonstrate improved recovery or safety for a particular blend. Names such as “CJC no DAC” also need careful identification; see the stacking guide.
Does ipamorelin cause weight gain?
Scale weight cannot distinguish fluid, fat and muscle. Controlled evidence does not establish a predictable body-composition benefit for healthy users.
How long does ipamorelin take to work?
A GH response was measurable during the short intravenous experiment. There is no established timetable for the advertised recovery, sleep or muscle outcomes.
Is ipamorelin legal?
FDA’s assessment states that there are no FDA-approved ipamorelin products. Research labeling is not an approval for human treatment; dispensing and possession rules depend on jurisdiction.
Sources
Study scope and regulatory evidence
- Raun et al., 1998: cell and animal pharmacology, not a human long-term safety trial.
- Gobburu et al., 1999: intravenous human PK/GH-response study.
- FDA 2024 ipamorelin assessment: clinical-development and compounding evidence review.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.